 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/22/2022 |
$157.69 |
$159.88 |
$157.56 |
$159.79 |
5.35M | | 11/23/2022 |
$159.95 |
$160.94 |
$158.82 |
$159.39 |
3.22M | | 11/25/2022 |
$159.59 |
$160.75 |
$159.24 |
$159.62 |
1.66M | | 11/28/2022 |
$160.00 |
$160.73 |
$157.83 |
$158.43 |
3.90M | | 11/29/2022 |
$158.31 |
$159.43 |
$157.21 |
$158.20 |
3.69M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid. | |
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on November 22, 2022, ABBV opened at $157.69, traded as high as $159.88 and as low as $157.56, and closed at $159.79. Trading volume was a total of 5.35M shares. On November 23, 2022, ABBV opened at $159.95, traded as high as $160.94 and as low as $158.82, and closed at $159.39. Trading volume was a total of 3.22M shares. On November 25, 2022, ABBV opened at $159.59, traded as high as $160.75 and as low as $159.24, and closed at $159.62. Trading volume was a total of 1.66M shares. On November 28, 2022, ABBV opened at $160.00, traded as high as $160.73 and as low as $157.83, and closed at $158.43. Trading volume was a total of 3.90M shares. On November 29, 2022, ABBV opened at $158.31, traded as high as $159.43 and as low as $157.21, and closed at $158.20. Trading volume was a total of 3.69M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/03/2013 |
|
| End date: |
11/29/2022 |
|
| Start price/share: |
$34.83 |
|
| End price/share: |
$158.20 |
|
| Starting shares: |
287.11 |
|
| Ending shares: |
432.65 |
|
| Dividends reinvested/share: |
$33.55 |
|
| Total return: |
584.45% |
|
| Average Annual Total Return: |
21.42% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$68,435.51 |
|
| Years: |
9.91 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/03/2013 |
|
| End date: |
11/29/2022 |
|
| Start price/share: |
$34.83 |
|
| End price/share: |
$158.20 |
|
| Dividends collected/share: |
$33.55 |
|
| Total return: |
450.53% |
|
| Average Annual Total Return: |
18.78% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$55,039.64 |
|
| Years: |
9.91 |
|
|
|
| Date |
Close |
| 11/22/2022 | $159.79 | | 11/23/2022 | $159.39 | | 11/25/2022 | $159.62 | | 11/28/2022 | $158.43 | | 11/29/2022 | $158.20 |
|
|
Free ABBV Email Alerts:
